PI
VIVO

PEAK6 Investments’s Meridian Bioscience Inc VIVO Stock Holding History

PEAK6 Investments’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-8,202
Closed -$153K – 5749
2020
Q4 		$153K Buy
8,202
+1,761
+27% +$32.9K ﹤0.01% 3868
2020
Q3 		$109K Buy
+6,441
New +$125K ﹤0.01% 3817

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

PEAK6 Investments's VIVO Position: Q1 2021 in Review

PEAK6 Investments sold out of Meridian Bioscience Inc (VIVO) in Q1 2021, closing a stake of 8,202 shares — an estimated $153K sold.

PEAK6 Investments first reported a position in VIVO in Q3 2020 and held it in 2 quarters. The position peaked at $153K in Q4 2020. 215 funds tracked by Wall St. Rank hold VIVO as of Q1 2021.

  • PEAK6 Investments reported no remaining Meridian Bioscience Inc position as of Q1 2021 after selling out during the quarter.
  • PEAK6 Investments sold 8,202 Meridian Bioscience Inc shares in Q1 2021, an estimated $153K.
  • PEAK6 Investments first reported a position in Meridian Bioscience Inc in Q3 2020 and held it in 2 quarters.
  • PEAK6 Investments's Meridian Bioscience Inc position peaked at $153K in Q4 2020.
  • 215 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2021.

Based on PEAK6 Investments's 13F filing for Q1 2021, filed 14 May 2021.